Home | Business News | Browse by Publication | M | M2 Presswire

Speak with other shareholders about: (NASD: VSGN), (OTCBB: UNFY), (OTCBB: ACHI), (OTC: ACBT), (OTCBB: IAGR).

Article Excerpt
M2 PRESSWIRE-28 February 2007-Stockwire.com: Speak with other shareholders about: (NASD: VSGN), (OTCBB: UNFY), (OTCBB: ACHI), (OTC: ACBT), (OTCBB: IAGR)(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:28022007

AUSTIN - A very interesting indicator to look for is where the money is flowing into. We have a filter that we watch every morning that shows us "Dollar Volume". Here are a few of these stocks: Vasogen Inc (NASD: VSGN), Unify Corp (OTCBB: UNFY), AmeriChip International Inc (OTCBB: ACHI), AccountAbilities Inc (OTC: ACBT), Internet Acquisitions (OTCBB: IAGR)

Have you ever watched a STOCKUMENTARY? http://www.stockwire.com .

For an in-depth look at VSGN:

http://www.stockwire.com/detailed/analysis.php?company=VSGN .

Talk to other VSGN shareholders by clicking the following link: http://www.stockwire.com/talkback?VSGN .

VASOGEN INC (NASD: VSGN) "Up 13.16% on Tuesday"

Vasogen is a biotechnology company engaged in the research and development of therapies that target the damaging inflammation associated with cardiovascular and neurodegenerative disorders. The Company's lead product, the Celacade(TM) technology, is designed to trigger the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade(TM) is in late-stage development for the treatment of chronic heart failure. The Company is also developing VP025, an early-stage new drug candidate for the treatment of certain neurodegenerative diseases.

VSGN News:

Vasogen Files Prospectus Supplement

Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), recently announced that it has filed a prospectus supplement with the Ontario Securities Commission and the U.S. Securities and Exchange Commission (SEC) to increase by 10 million the number of common shares that may be sold by certain selling shareholders in connection with the senior convertible notes issued in October 2005 by Vasogen Ireland Limited (VIL), a wholly-owned subsidiary of Vasogen Inc. As of February 20, 2007, the outstanding principal amount owing under the notes was US$2.8 million. VIL may continue to repay the outstanding principal on a monthly basis over the remaining term of the notes in any combination of cash or common shares at its sole discretion, provided certain conditions are met. Based on such regular monthly instalments, the outstanding principal amount of the notes will be completely repaid with the final instalment for April 1, 2007. Given VIL's right to pay in cash and the potential fluctuation of the Company's share price, the number of shares actually issued may be significantly different from the number covered by the prospectus supplement.

UNIFY CORP (OTCBB: UNFY) "Up 11.70% on Tuesday"

For an in-depth look at UNFY:

http://www.stockwire.com/detailed/analysis.php?company=UNFY .

Talk to other UNFY shareholders by clicking the following link: http://www.stockwire.com/talkback?UNFY .

Unify (OTCBB:UNFY) provides business automation solutions, including specialty market applications for the insurance and transportation industries. Unify's solutions deliver a broad set of capabilities for automating business processes, integrating existing information systems and delivering collaborative information. Through its industry expertise and market leading technologies, Unify helps...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!